Meet your enrollment goals faster by recruiting from Evidation’s
engaged, highly characterized health community.
Quickly connect the right participants to your trial
Related Posts
Johnson & Johnson’s Shockwave Medical Shares First Clinical Outcomes Associated With its IVL Catheter
Image Credit: © Tamara – stock.adobe.com Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outcomes…
Tremfya Shows Superior Endoscopic Remission Rates in Crohn Disease, Ulcerative Colitis
Credit: luchschenF | stock.adobe.com Pooled data from the Phase III GALAXI trial (NCT03466411) and the Phase III QUASAR maintenance trial…
Tecentriq Falls Short of Primary Endpoint in IMvoke010 Trial for Locally Advanced Head and Neck Cancer
Credit: urwa | stock.adobe.com Maintenance treatment with Tecentriq (atezolizumab) was not found to produce a significant improvement in event-free survival…